keyboard_arrow_up

JSB Market Research: Schizophrenia - Pipeline Review, H1 2014

Summary

This report "Schizophrenia - Pipeline Review, H1 2014'' provides comprehensive information on the therapeutic development for Schizophrenia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Schizophrenia and special features on late-stage and discontinued projects.

Browse Full Report @ http://www.jsbmarketresearch.com/healthcare-medical/r-Schizophrenia-Pipeline-Review-118888

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global therapeutic landscape of Schizophrenia
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Schizophrenia and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Schizophrenia products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Schizophrenia pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for Schizophrenia
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Schizophrenia pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Content:

Introduction 7
Schizophrenia Overview 8
 Therapeutics Development 9
 Schizophrenia - Therapeutics under Development by Companies 11
 Schizophrenia - Therapeutics under Investigation by Universities/Institutes 18
 Schizophrenia - Pipeline Products Glance 20
 Schizophrenia - Products under Development by Companies 24
 Schizophrenia - Products under Investigation by Universities/Institutes 33
 Schizophrenia - Companies Involved in Therapeutics Development 34
 Schizophrenia - Therapeutics Assessment 113
 Drug Profiles 134
 Schizophrenia - Recent Pipeline Updates 319
 Schizophrenia - Dormant Projects 359
 Schizophrenia - Discontinued Products 362
 Schizophrenia - Product Development Milestones 363
 Appendix 372


For More Related Market Research Reports click here

Garden Fresh Restaurant Corp: Foodservice - Company Profile and SWOT Report

Healthcare and Medical Market Research


About JSB Market Research -
JSB Market Research is one of the most significant databases of online market researches and intelligence reports and services. We specialize in providing market research reports for various industries. The online portal for marketing research deals with access to global market data and assists in providing expert insights and exposure on global companies, industries, products and trends.

Contact –
Tel: + 91 - 22 – 41236650
Website: http://www.jsbmarketresearch.com

Email - contact@jsbmarketresearch.com

Blog: http://www.jsbmarketresearch.com/blog/